- Catalogs
- MICOBIOMED
- micobiomed-COVID19
micobiomed-COVID19
micobiomed-COVID19
In the context of the COVID-19 pandemic, there is a critical need for rapid and reliable diagnostic solutions that can be deployed at the point of care. Traditional laboratory testing is too slow to meet the urgent demands of public health officials, patients, and healthcare providers who require immediate results to prevent further virus spread.
The VERI-Q™ PCR 316 platform offers a near point-of-care diagnostic solution that delivers results within one hour. This system is CE-IVD marked and manufactured in South Korea. It allows for on-site testing, providing quick and accurate results to facilitate immediate patient management.
By enabling rapid detection of SARS-CoV-2, the VERI-Q PCR 316 platform helps in the swift isolation and treatment of COVID-19 positive patients, thereby reducing the risk of transmission. The platform's high sensitivity and specificity are achieved through the use of two target primer and probe sets targeting the N and ORF genes.
- Real-time PCR with a fast reaction time of 37 minutes per run.
- Compatible with nasopharyngeal, oropharyngeal swab, and sputum samples.
- Automated nucleic acid extraction to eliminate manual processing steps.
- Microfluidic LabChip® disposables for efficient testing.
- Amplifier dimensions: 274 mm x 160 mm x 206 mm, weight: 4.7 kg.
- Extractor dimensions: 260 mm x 335 mm x 355 mm, weight: 13.3 kg.
MiCo BioMed Co., Ltd., South Korea: [email protected], Tel: 82-70-5227-6021
MiCo BioMed USA, Inc.: [email protected], Tel: +1-513-328-2267
Catalog excerpts
Detection Platform 1 hour detection of SARS-CoV-2 The Need In responding to the current novel coronavirus pandemic, front–line caretakers require a new paradigm of diagnostics than what conventional labs can provide. Public health officials cannot afford to stand by for lab results and risk further spread of the virus. Moreover, patients and doctors are unwilling to wait days to receive results. We need a point-of-care solution: a solution that provides fast, accurate, and reliable confirmatory diagnosis. The Solution ■ PCR 316 COVID-19 Kit: near point-of care diagnostics in 1 hour ■ Patients get test results on site ■ CE-IVD marked ■ Made in South Korea The Impact 1 hour Patient Presents with COVID-19 Symptoms Collect Sample at Point-of-care Release Patient 3,4th Floor 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, South Korea Web: www.micobiomed.com E-mail: [email protected] Tel: 82-70-5227-6021 10999 Reed Hartman Hwy, Cincinnati, OH 45242 E-mail: [email protected] Tel: +1-513-328-2267 Easy Answers to Life Through innovative Point-of-care Di
Open the catalog to page 1
Product Information ✓ Rapid and accurate Real-time PCR ✓ Microfluidic LabChip® disposables ✓ Printable <S> SARS-CoV-2 Test High sensitivity (LoD) and specificity High accuracy using two target primer and probe sets (N and ORF genes) Nasopharyngeal, oropharyngeal swab and sputum samples Two reactions per test Fast reaction; Only 37 min per a run for Real-time PCR MiCo BioMed Co., Ltd. 3,4th Floor 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, South Korea Web: www.micobiomed.com E-mail: [email protected] Tel: 82-70-5227-6021 MiCo BioMed USA, Inc. 10999 Reed Hartman Hwy, Cincinnati,...
Open the catalog to page 2All MICOBIOMED catalogs and technical brochures
VERI-Q multi4 Pages
Molecular Diagnostics2 Pages
VERI-Q opti96 plate2 Pages
VERI-Q balance2 Pages
- Solvent reagent
- Molecular biology reagent
- Blood rapid screening test
- Laboratory reagent
- Immunoassay rapid diagnostic test
- Rapid virus test
- Sample preparation system
- Automatic sample processor
- Microtiter plate
- Rapid respiratory disease test
- PCR reagent
- Laboratory sample preparation system
- 96-well microplate
- COVID-19 rapid test
- Laboratory microplate
- PCR system
- Compact PCR machine
- Real-time PCR analyzer
- Tissue processor
- Immunoassay microplate